5XST
novel orally efficacious inhibitors complexed with PARP1
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | SSRF BEAMLINE BL17U1 |
| Synchrotron site | SSRF |
| Beamline | BL17U1 |
| Temperature [K] | 100 |
| Detector technology | CCD |
| Collection date | 2012-03-22 |
| Detector | ADSC QUANTUM 315r |
| Wavelength(s) | 0.9793 |
| Spacegroup name | P 65 2 2 |
| Unit cell lengths | 93.980, 93.980, 222.800 |
| Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
| Resolution | 39.709 - 2.300 |
| R-factor | 0.203 |
| Rwork | 0.202 |
| R-free | 0.23560 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 4hhy |
| RMSD bond length | 0.008 |
| RMSD bond angle | 0.960 |
| Data reduction software | XDS |
| Data scaling software | XSCALE |
| Phasing software | PHASER |
| Refinement software | PHENIX (1.11.1_2575: ???) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 39.709 | 39.709 | 2.360 |
| High resolution limit [Å] | 2.300 | 10.290 | 2.300 |
| Rmerge | 0.060 | 0.024 | 0.802 |
| Rmeas | 0.065 | 0.026 | 0.876 |
| Number of reflections | 48849 | 522 | 3609 |
| <I/σ(I)> | 17.95 | 43.51 | 2.26 |
| Completeness [%] | 99.9 | 94.6 | 99.9 |
| Redundancy | 6.32 | 5.724 | 6.36 |
| CC(1/2) | 0.999 | 0.999 | 0.759 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, HANGING DROP | 283 | 80mM NaCl, 1.9M (NH4)2SO4 |






